The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and
hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top …

Background In 2016, of the estimated 257 million people living with chronic hepatitis B virus
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …

This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …

Web Annexes Page 1 Page | i GUIDELINES ON HEPATITIS B AND C TESTING February 2017
GUIDELINES ANNEXES Page 2 Page | ii WHO guidelines on hepatitis B and C testing ISBN …

The WHO global health sector strategy on viral hepatitis, created in May, 2016, aims to
achieve a 90% reduction in new cases of chronic hepatitis B and C and a 65% reduction in …

Background Despite the existence of effective prevention and treatment interventions,
hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO …

Hepatitis B virus (HBV) infection is a major cause of acute and chronic liver disease and
associated morbidity and mortality worldwide. Vertical (mother-to-child) and horizontal early …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Abstract In sub-Saharan Africa, simple biomarkers of liver fibrosis are needed to scale-up
hepatitis B treatment. We conducted an individual participant data meta-analysis of 3,548 …

Background China has the highest prevalence of hepatitis B virus (HBV) infection
worldwide. Universal HBV screening might enable China to reach the WHO 2030 target of …